Core Viewpoint - The company plans to use up to RMB 500 million of its idle funds to purchase low-risk financial products, aiming to enhance investment returns while ensuring normal business operations are not affected [1][2][4]. Investment Overview - The company intends to invest a maximum of RMB 500 million of its idle funds in low-risk financial products, with the ability to roll over the funds within this limit [2][3]. - The investment will be limited to financial products with a maturity of no more than one year and will not include other securities investments or products linked to stocks or unsecured bonds [2][4]. Risk Control Measures - The company will select reputable financial institutions with strong credit ratings for the investment and will formalize agreements detailing the investment amount, duration, and responsibilities [2][3]. - Internal audits and oversight by independent directors and the supervisory board will be implemented to monitor the use of funds [3][4]. Impact on the Company - The investment in low-risk financial products is expected to enhance the company's investment returns without disrupting normal cash flow or core business operations [3][4]. Approval Process - The proposal was approved in the board and supervisory meetings held on June 30, 2025, and will be submitted for shareholder approval [3][4].

Group 1: Financial Performance - The company's net profit attributable to shareholders decreased year-on-year in 2024, but operating cash flow remains robust [2] - As of the end of 2024, the cumulative undistributed profits on the consolidated balance sheet amounted to RMB 1.261 billion, while the parent company's undistributed profits were RMB 1.12 billion [2] - The profit distribution plan for 2024 is to distribute RMB 5 per 10 shares (including tax) based on a total share capital of 400,010,000 shares [2][3] Group 2: Dividend Policy - The company has established a scientific, continuous, and stable dividend mechanism, responding positively to national dividend policy calls [3] - The company aims to maintain the stability and transparency of its dividend policy to reward long-term shareholder support [3] Group 3: Cash Management and Investments - As of the end of Q1 2025, the company had cash and cash equivalents exceeding RMB 6 billion [3] - The company plans to use no more than RMB 900 million to purchase land use rights in Shenzhen, with a total land transaction price of RMB 466 million [3] - The company will invest in the construction of a modern fashion creative industry headquarters project to meet future business development needs [3] Group 4: Strategic Direction - The company will leverage its expertise in emotional expression and existing supply chain advantages to explore suitable investment directions through internal incubation, external acquisitions, or strategic partnerships [3] - Discussions with investors also covered industry prospects, future strategies, and key focus areas for brand/product/channel work in the second half of the year [3]

Group 1 - The company has redeemed all structured deposit products amounting to 35 million yuan, with the principal and investment returns returned to the fundraising account [2] - The structured deposit product was managed by Hangzhou Bank, with an expected annual yield of 2.3% to 2.5% [2] - The total amount of idle fundraising funds used for entrusted wealth management in the last twelve months was 220 million yuan, with actual returns of 1.1052 million yuan [2] Group 2 - The highest single-day investment amount in the last twelve months was 5 million yuan, which represents 3.20% of the net assets for the past year [2] - The cumulative returns from entrusted wealth management in the last twelve months accounted for 0.76% of the net profit for the past year [2] - The company currently has an unused wealth management quota of 120 million yuan out of a total quota of 120 million yuan [2]

Group 1 - The company Shenzhen Kelik Technology Co., Ltd. has approved the use of up to RMB 160 million of temporarily idle raised funds to purchase low-risk, high-liquidity wealth management products, with a usage period not exceeding 12 months [1][2] - The board meetings held on January 23, 2025, and April 9, 2025, confirmed the decision to invest idle funds while ensuring the normal operation of fundraising projects and maintaining fund safety [1][2] - The company aims to improve the efficiency of fund utilization and enhance overall performance, thereby safeguarding shareholder interests [4] Group 2 - The company has a history of using funds for wealth management products, with a cumulative amount used in the past twelve months detailed in the announcements [4] - Specific wealth management products purchased include those with expected annualized returns ranging from 0.60% to 2.39%, depending on the product type and market conditions [3][4][5] - The company emphasizes the importance of selecting financial products that meet criteria for liquidity and safety to mitigate investment risks [3][4]

Core Viewpoint - Lisheng Pharmaceutical (002393) has seen a significant increase in stock price, reaching a nearly one-year high, and is actively managing idle funds through short-term financial products [1][2]. Company Stock Performance - As of June 13, 2025, Lisheng Pharmaceutical's stock closed at 22.11 yuan, up 13.79% from the previous week [1]. - The stock reached a peak of 22.11 yuan during the week and a low of 19.5 yuan [1]. - The company's current market capitalization is 5.698 billion yuan, ranking 83rd out of 150 in the chemical pharmaceutical sector and 2608th out of 5150 in the A-share market [1]. Company Announcements - Lisheng Pharmaceutical announced the use of up to 1 billion yuan of idle self-owned funds for cash management, investing in short-term financial products with a maturity of no more than 12 months [2]. - The company has invested 50 million yuan in financial products from Industrial Bank, including 10 million yuan in a flexible income product and 40 million yuan in a stable income product, with expected yields of approximately 2% and 2.2% respectively [2]. - The total amount of idle self-owned funds invested in financial products as of the announcement date is 639 million yuan, which is within the authorized limit [2]. Fund Management - Lisheng Pharmaceutical also plans to use up to 600 million yuan of idle raised funds for cash management, investing in short-term financial products with a maturity of no more than 12 months [2]. - The company has invested 50 million yuan in structured deposits from Industrial Bank, with an expected annual yield of 1.20%-1.80% [2]. - The total amount of idle raised funds invested in financial products as of the announcement date is 85 million yuan, also within the approved limit [2].

Meeting Overview - The 14th Supervisory Board meeting of Shanxi Meijin Energy Co., Ltd. was held on June 12, 2025, via communication, with all three supervisors participating [2][4]. - The meeting was chaired by Ms. Wang Lizhu and complied with relevant laws and regulations [2]. Resolutions Passed - The Supervisory Board unanimously approved the proposal to use part of the idle raised funds for cash management, allowing up to 300 million yuan to be temporarily utilized for purchasing cash yield products with a maximum term of one year [3][21]. - The cash management aims to enhance the efficiency of fund usage while ensuring the normal progress of fundraising projects [3][20]. Fundraising Background - The company raised a total of 3.59 billion yuan through the issuance of convertible bonds, with a net amount of approximately 3.56 billion yuan after deducting related expenses [8][9]. - As of August 31, 2022, there was a remaining balance of 306.29 million yuan in idle raised funds due to the phased implementation of investment projects [10]. Cash Management Details - The cash management will involve low-risk, high-liquidity products such as seven-day notice deposits and fixed-term deposits, with no involvement in high-risk investments [11][13]. - The management is authorized to make investment decisions within the approved limits and duration, which is valid for one year from the date of approval [12][14]. Impact on Company Operations - The use of idle funds for cash management is expected to improve fund efficiency and operational performance without affecting the normal operations of the company or its main business [20][39]. - The Supervisory Board and the sponsor institution have expressed no objections to the cash management proposal, confirming that it complies with legal regulations and does not harm shareholder interests [22][23].

Meeting Overview - The 38th meeting of the 10th Board of Directors of Shanxi Meijin Energy Co., Ltd. was held on June 12, 2025, via communication, with all 9 directors participating, including 3 independent directors [1] - The meeting was chaired by Chairman Yao Jinlong, and the procedures complied with relevant laws and regulations [1] Resolutions Passed - The Board authorized the use of up to 300 million yuan of temporarily idle raised funds for cash management, allowing investment in cash yield products with a maximum term of one year, effective for one year from the meeting date [1] - The management has the authority to make cash management decisions within this limit and sign relevant documents [1] - The Board also approved the use of up to 1.5 billion yuan of idle self-owned funds for short-term investment products, ensuring normal operations and project construction are not affected [2] - Similar to the previous resolution, the management will have decision-making authority within this limit [2] Convertible Bond Adjustment - As of June 12, 2025, the company's stock triggered the downward adjustment clause for the "Meijin Convertible Bond" conversion price [2] - The Board decided not to exercise the right to adjust the conversion price downward, considering the company's fundamentals, stock performance, and market conditions [3] - If the downward adjustment clause is triggered again after June 13, 2025, the Board will convene to decide on the matter [3]

Group 1 - The company Chengdu Kanghong Pharmaceutical Group Co., Ltd. has approved the use of idle funds to purchase financial products up to RMB 3.8 billion, focusing on high safety and liquidity products issued by commercial banks [1] - The investment decision will be executed by the company's president or financial officer, with the finance department responsible for the specific purchases [1] - The company has previously invested a total of RMB 2.245 billion in bank principal-protected financial products over the past twelve months, which is within the authorized investment limits [11] Group 2 - The company’s subsidiaries, Chengdu Kanghong Biotechnology Co., Ltd. and Sichuan Kanghong Pharmaceutical Trading Co., Ltd., have utilized their own funds to purchase financial products [2] - The financial products purchased include structured deposits from China Bank and Chengdu Bank, with specific details on expected returns and conditions outlined [4][7] - The expected annualized return for some products is between 0.79% and 3.17%, depending on market conditions and performance indicators [2][3]

Core Viewpoint - Dongguan Qianshang Optoelectronics Co., Ltd. has announced the establishment of special settlement accounts for cash management of idle raised funds, allowing the use of up to 1 billion yuan of idle self-owned funds and up to 600 million yuan of idle raised funds for cash management [1][2]. Group 1: Fund Management and Investment - The company has opened special settlement accounts at Shanghai Pudong Development Bank, Industrial Bank, and Dongguan Rural Commercial Bank for cash management purposes [1]. - A total of 358.03 million yuan of idle raised funds has been used for cash management, with specific financial products purchased [2][3]. - The investment products include principal-protected structured deposits with floating returns, ensuring the safety of the company's daily operations and funds [4][12]. Group 2: Financial Products and Returns - The purchased financial products are structured deposits with varying terms and expected annualized returns, contributing to the efficient use of idle funds [2][4]. - The company has outlined the expected returns and terms for each financial product, indicating a focus on maximizing investment efficiency while maintaining capital safety [4][12]. Group 3: Regulatory Compliance and Oversight - The company will comply with relevant regulations regarding the management and use of raised funds, ensuring that the special accounts are exclusively used for cash management [1][4]. - The finance department will monitor the investment products, and the audit department will oversee the cash management activities to mitigate potential risks [3][4].

Core Viewpoint - The company Hu Guang Co., Ltd. (605333) has experienced a decline in stock price, closing at 27.66 yuan, down 3.05% from the previous week, with a current market capitalization of 12.081 billion yuan [1] Company Announcements - The wholly-owned subsidiary, Chongqing Hu Guang Automotive Electric Co., Ltd., has invested 100 million yuan of idle funds in a structured deposit product from Bank of Communications, with an expected annual yield of 1.20% to 1.60%, linked to the EUR/USD exchange rate [2] - The decision to use idle funds for financial products was approved in multiple meetings and will not adversely affect the company's operations [2] - The annual profit distribution announcement states that a cash dividend of 0.23 yuan per share (before tax) will be distributed, with the record date set for June 11, 2025, and the payment date on June 12, 2025 [3] - The total cash dividend payout amounts to approximately 100.46 million yuan, based on a total share capital of 436,776,081 shares [3] - Tax implications for different shareholder categories are outlined, with a 10% withholding tax applicable for certain investors, resulting in a net dividend of 0.207 yuan per share for those subject to tax [3]